$GeoVax Labs (GOVX.US)$ "The COVID-19 vaccine candidate COH0...

$GeoVax Labs (GOVX.US)$ "The COVID-19 vaccine candidate COH04S1, developed by City of Hope and licensed to GeoVax, has shown promise in protecting against Mpox (formerly known as monkeypox) in addition to COVID-19. This dual protection is due to the vaccine's use of a synthetic modified vaccinia Ankara (MVA) vector, which is similar to the MVA strain used in the JYNNEOS vaccine, currently the only FDA-approved vaccine for smallpox and Mpox.
Research has demonstrated that COH04S1 can elicit a cross-reactive antibody response against Mpox, offering a potential alternative to JYNNEOS, especially in cases of large outbreaks or vaccine shortages. The vaccine is currently in Phase 2 clinical trials and has not yet received FDA approval. The approval timeline remains uncertain, as the vaccine is still under investigation, but it represents a promising candidate for dual protection against both COVID-19 and Mpox.
Regarding approval timelines, the WHO has recently invited manufacturers to submit dossiers for Emergency Use Listing (EUL) for Mpox vaccines due to rising concerns about the spread of the disease. However, no specific date for FDA approval of COH04S1 has been confirmed​."